ITMI20031349A1 - ANTAGONISTS OF THE NOP RECEPTOR AND THEIR THERAPEUTIC USES. - Google Patents

ANTAGONISTS OF THE NOP RECEPTOR AND THEIR THERAPEUTIC USES.

Info

Publication number
ITMI20031349A1
ITMI20031349A1 IT001349A ITMI20031349A ITMI20031349A1 IT MI20031349 A1 ITMI20031349 A1 IT MI20031349A1 IT 001349 A IT001349 A IT 001349A IT MI20031349 A ITMI20031349 A IT MI20031349A IT MI20031349 A1 ITMI20031349 A1 IT MI20031349A1
Authority
IT
Italy
Prior art keywords
antagonists
therapeutic uses
nop receptor
nop
receptor
Prior art date
Application number
IT001349A
Other languages
Italian (it)
Inventor
Matteo Marti
Michele Morari
Original Assignee
Ufpeptides S R L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ufpeptides S R L filed Critical Ufpeptides S R L
Priority to IT001349A priority Critical patent/ITMI20031349A1/en
Publication of ITMI20031349A0 publication Critical patent/ITMI20031349A0/en
Priority to PCT/EP2004/006826 priority patent/WO2005004896A1/en
Publication of ITMI20031349A1 publication Critical patent/ITMI20031349A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10Peptides having 12 to 20 amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Psychology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IT001349A 2003-07-01 2003-07-01 ANTAGONISTS OF THE NOP RECEPTOR AND THEIR THERAPEUTIC USES. ITMI20031349A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
IT001349A ITMI20031349A1 (en) 2003-07-01 2003-07-01 ANTAGONISTS OF THE NOP RECEPTOR AND THEIR THERAPEUTIC USES.
PCT/EP2004/006826 WO2005004896A1 (en) 2003-07-01 2004-06-24 Nop receptor antagonists for the treatment of parkinson’s disease

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT001349A ITMI20031349A1 (en) 2003-07-01 2003-07-01 ANTAGONISTS OF THE NOP RECEPTOR AND THEIR THERAPEUTIC USES.

Publications (2)

Publication Number Publication Date
ITMI20031349A0 ITMI20031349A0 (en) 2003-07-01
ITMI20031349A1 true ITMI20031349A1 (en) 2005-01-02

Family

ID=30131341

Family Applications (1)

Application Number Title Priority Date Filing Date
IT001349A ITMI20031349A1 (en) 2003-07-01 2003-07-01 ANTAGONISTS OF THE NOP RECEPTOR AND THEIR THERAPEUTIC USES.

Country Status (2)

Country Link
IT (1) ITMI20031349A1 (en)
WO (1) WO2005004896A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITFE20050003A1 (en) 2005-02-15 2006-08-16 Ufpeptides S R L FULL AND PARTIAL AND ANTAGONIST AGONISTS OF THE NOCICETTINA / ORPHANINE FQ RECEPTOR OF HIGH POWER.
WO2016003886A1 (en) * 2014-07-02 2016-01-07 Lam Therapeutics, Inc. 4-aminoquinoline compositions and methods for using same
CN114642744B (en) * 2022-02-09 2023-05-23 南京医科大学 Method for screening morphine-tolerance-relieving drugs

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4366532B2 (en) * 1997-05-30 2009-11-18 萬有製薬株式会社 2-oxoimidazole derivatives
CO5150201A1 (en) * 1998-09-07 2002-04-29 Hoffmann La Roche PIPERIDINE DERIVATIVES
ES2237047T3 (en) * 1998-10-23 2005-07-16 Pfizer Inc. 1,3,8-TRIAZAESPIRO (4,5) DECANONE COMPOUNDS AS ORL1 RECEIVER AGONISTS.
WO2001032178A1 (en) * 1999-10-29 2001-05-10 Novo Nordisk A/S Use of 3,4-substituted piperidines
WO2003064425A1 (en) * 2002-01-28 2003-08-07 Pfizer Japan Inc. N-substituted spiropiperidine compounds as ligands for orl-1 receptor

Also Published As

Publication number Publication date
WO2005004896A1 (en) 2005-01-20
ITMI20031349A0 (en) 2003-07-01

Similar Documents

Publication Publication Date Title
BRPI0809795A2 (en) "TRPV1 ANTAGONISTS AND USES OF THIS".
IS7894A (en) Dosage form with allergy
ATE486091T1 (en) VEGF TRAPES AND THERAPEUTIC USES THEREOF
ATE413400T1 (en) CGRP RECEPTOR ANTAGONISTS
IS7689A (en) Multiple component dosage forms
DE60315135D1 (en) therapy probe
DK1773796T3 (en) Oxopiperidine derivatives, their preparation and their therapeutic use
DE602005021959D1 (en) SUBSTITUTED DIAZASPIROÄ4.5ÜDECANDERIVATE AND DER
ITRM20050103A1 (en) ASSOCIATION OF ANTAGONISTS OF THE INTERLEUCHINE 6 AND ANTIPROLIFERATIVE DRUGS.
NO20050689L (en) Therapeutic use
DE602004027811D1 (en) CYCLOPROPYL GROUP SUBSTITUTED OXAZOLIDINONANTIBIOTICS AND DERIVATIVES THEREOF
ATE460415T1 (en) THERAPEUTIC PYRAZOLOA3,4-BUPYRIDINES AND INDAZOLES
DK1597171T3 (en) THERAPEUTIC MICROSUM
ITMI20042007A1 (en) "GPR17 RECIPE MODULATORS AND THEIR THERAPEUTIC USES"
DE60312105D1 (en) Interconnects
ITMI20031349A1 (en) ANTAGONISTS OF THE NOP RECEPTOR AND THEIR THERAPEUTIC USES.
NO20053189D0 (en) HVC-combination therapy.
DE60311724D1 (en) Interconnects
ITTO20030246A1 (en) NEW CITRULLINATED SYNTHETIC PEPTIDES AND THEIR USES.
ES1058102Y (en) THERAPEUTIC LENTILLA.
IT1317908B1 (en) MUTEINE OF THE PEPTIDIC FRAGMENT CGRP 1-7 AND THEIR USE AS POTENTIATOR OF NEURONAL NICOTINIC RECEPTORS.
FI20041385A0 (en) Defining the axis of symmetry
NO20041344A (en) Lens device and use of the lens device.
FI20020049A0 (en) Sõhk ÷ central structure
ES1058914Y (en) PORTABLE DELIMITATOR OF THE PLAYING LAND